Business Development Deal Architecture
  • Search OnBioBD:

  • OnBioBD OldSkool NEWS:

    - OnBioVC 4Q11 Trend Analysis, now available
    - OnBioVC 1Q12 White Paper, now available
    - OnBioVC 1Q12 Trend Analysis, coming soon

  • FDA Registered Contract Manufacturer

Advanced Cardiac Therapeutics (Laguna Beach, CA) a development-stage electrophysiology and radiometry medical device company focused on energy delivery via catheters for cardiac ablation, closed a $5M Series b financing. Participants include NBGI Ventures.

Curetis (Germany) molecular diagnostics company focused on tuberculosis and other severe infectious diseases closed a $1.9M Series A financing. Participants include Aeris Capital.

Prosena (The Netherlands) developer of RNA-based splice modulating therapeutics closed a $25M Series B financing. Participants include GIMV, AGF Management, Abingworth Management, Life Sciences Partnersand MedSciences Capital.

Entra Pharmaceuticals (Waltham, MA) a stealthy drug delivery company closed a $4.2M Series A financing. Participants include Flybridge Capital Partners and North Bridge Venture Partners.

CalciMedica (La Jolla, CA) an early-stage company focused on the calcium release-activated calcium channel is pursuing autoimmune and inflammatory indications, closed a $4M Series C financing. Participants include Biogen Idec, Sanderling Ventures and SR One.

Pioneer Surgical Technology (Marquette, MI) a commercial-stage spinal and orthopedic implant and instrument company closed a $15M Series B financing. Participants include InvestMichigan Growth Capital Fund, Pharos Capital Group, Highlander Partners, Hopewell Ventures and River Cities Capital Funds.

Rcadia Medical Imaging (Israel) developer of image processing based software products for blood vessel analysis closed a $3.3M Series B financing. Participants include BioVentures Investors and 20/20 HealthCare Partners.

ESTECH (San Ramon, CA) a commercial-stage developer, manufacturer and distributor of cardiac surgery devices closed a $11.2M Series B financing. Participants include Saints Capital Everest, Telegraph Hill Partners and Waveland Venture Partners.

Seventh Sense Biosystems (Cambridge, MA) a stealthy early-stage health monitoring and telemedicine device company closed a $4.8M Series A financing. Participants include Flagship Ventures, Polaris Venture Partners and Third Rock Ventures.

Semprus BioSciences (Cambridge, MA) an early-stage biomaterial surface coating company closed a $8M Series A financing. Participants include 5AM Ventures and Panagea Ventures.

Healionics (Redmond, WA) an early-stage biomaterial surface coating and tissue regeneration company closed a $2.6M Series B financing. Participants include Bellingham Angels, Alliance of Angels, Keiretsu, Tacoma Angel Network and Zino Society.

Diagnoplex (Switzerland) an early stage molecular diagnostic company focused on non-invasive colorectal cancer screening closed a $8.3M Series A financing. Participants include Novartis Venture Fund, NeoMed and Initiative Capital Romandie.

Interface Biologics (Canada) an early-stage developer of therapeutic biomaterials for use in implantable medical devices closed a $5M Series C financing. Participants include Covington Capital, VG Partners and BDC Capital.

« Previous Entries  Next Page »

to top of page...